These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8215637)

  • 1. The development of gene therapy for the treatment of cancer.
    Rosenberg SA; Anderson WF; Blaese M; Hwu P; Yannelli JR; Yang JC; Topalian SL; Schwartzentruber DJ; Weber JS; Ettinghausen SE
    Ann Surg; 1993 Oct; 218(4):455-63; discussion 463-4. PubMed ID: 8215637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin.
    Merrouche Y; Negrier S; Bain C; Combaret V; Mercatello A; Coronel B; Moskovtchenko JF; Tolstoshev P; Moen R; Philip T
    J Clin Oncol; 1995 Feb; 13(2):410-8. PubMed ID: 7844602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
    Ogasawara M; Rosenberg SA
    Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects for gene therapy and lymphokine therapy for metastatic melanoma.
    Sivanandham M; Scoggin SD; Sperry RG; Wallack MK
    Ann Plast Surg; 1992 Jan; 28(1):114-8. PubMed ID: 1642399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction.
    Rosenberg SA; Aebersold P; Cornetta K; Kasid A; Morgan RA; Moen R; Karson EM; Lotze MT; Yang JC; Topalian SL
    N Engl J Med; 1990 Aug; 323(9):570-8. PubMed ID: 2381442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man.
    Kasid A; Morecki S; Aebersold P; Cornetta K; Culver K; Freeman S; Director E; Lotze MT; Blaese RM; Anderson WF
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):473-7. PubMed ID: 2404283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study.
    Goedegebuure PS; Douville LM; Li H; Richmond GC; Schoof DD; Scavone M; Eberlein TJ
    J Clin Oncol; 1995 Aug; 13(8):1939-49. PubMed ID: 7636534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-alpha cDNA for the gene therapy of cancer in humans.
    Hwu P; Yannelli J; Kriegler M; Anderson WF; Perez C; Chiang Y; Schwarz S; Cowherd R; Delgado C; Mulé J
    J Immunol; 1993 May; 150(9):4104-15. PubMed ID: 8473752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetic modification of T cells for cancer therapy: an overview of laboratory and clinical trials.
    Hwu P; Rosenberg SA
    Cancer Detect Prev; 1994; 18(1):43-50. PubMed ID: 8162605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transduction of rIL-2 expanded CD4+ and CD8+ ovarian TIL-derived T cell lines with the G1Na (neor) replication-deficient retroviral vector.
    Nash MA; Platsoucas CD; Wong BY; Wong PM; Cottler-Fox M; Otto E; Freedman RS
    Hum Gene Ther; 1995 Nov; 6(11):1379-89. PubMed ID: 8573611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of tumor-necrosis-factor-gene-transduced tumor-infiltrating lymphocytes from ascitic fluid of cancer patients: analysis of cytolytic activity, growth rate, adhesion molecule expression and cytokine production.
    Itoh Y; Koshita Y; Takahashi M; Watanabe N; Kohgo Y; Niitsu Y
    Cancer Immunol Immunother; 1995 Feb; 40(2):95-102. PubMed ID: 7882388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of gene-marked tumor infiltrating lymphocytes from post-treatment biopsies: a case study.
    Aebersold P; Kasid A; Rosenberg SA
    Hum Gene Ther; 1990; 1(4):373-84. PubMed ID: 1964094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for cancer.
    Rosenberg SA
    JAMA; 1992 Nov; 268(17):2416-9. PubMed ID: 1404800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients.
    Besser MJ; Shapira-Frommer R; Treves AJ; Zippel D; Itzhaki O; Hershkovitz L; Levy D; Kubi A; Hovav E; Chermoshniuk N; Shalmon B; Hardan I; Catane R; Markel G; Apter S; Ben-Nun A; Kuchuk I; Shimoni A; Nagler A; Schachter J
    Clin Cancer Res; 2010 May; 16(9):2646-55. PubMed ID: 20406835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes.
    Hwu P; Yang JC; Cowherd R; Treisman J; Shafer GE; Eshhar Z; Rosenberg SA
    Cancer Res; 1995 Aug; 55(15):3369-73. PubMed ID: 7614473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor tissue recycling--a new combination treatment for solid tumors: experimental and preliminary clinical research.
    Li B; Ding J; Larson A; Song S
    In Vivo; 1999; 13(5):433-8. PubMed ID: 10654199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristic cytokine generation patterns in cancer cells and infiltrating lymphocytes in oral squamous cell carcinomas and the influence of chemoradiation combined with immunotherapy on these patterns.
    Yamamoto T; Kimura T; Ueta E; Tatemoto Y; Osaki T
    Oncology; 2003; 64(4):407-15. PubMed ID: 12759539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer therapy with tumor-infiltrating lymphocytes: evaluation of potential and limitations.
    Whiteside TL
    In Vivo; 1991; 5(6):553-9. PubMed ID: 1810438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens.
    Rosenberg SA
    Annu Rev Med; 1996; 47():481-91. PubMed ID: 8712798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.
    Roszkowski JJ; Lyons GE; Kast WM; Yee C; Van Besien K; Nishimura MI
    Cancer Res; 2005 Feb; 65(4):1570-6. PubMed ID: 15735047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.